Flurazepam
(ZIIJJOPLRSCQNX-UHFFFAOYSA-N)
Structure
- SMILES
- CCN(CCN1C(=O)CN=C(c2c1ccc(c2)Cl)c1ccccc1F)CC.Cl.Cl
- Molecular Formula:
- C21H25Cl3FN3O
- Molecular Weight:
- 460.800
- Log P:
- 5.1095
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 2
- TPSA:
- 35.91
- CAS Number(s):
- 1172-18-5
Synonym(s)
1.
Flurazepam
2.
Apo-Flurazepam
3.
Dalmadorm
4.
Dalmane
5.
Dormodor
6.
Flurazepam Dihydrochloride
7.
Flurazepam Hydrochloride
8.
Flurazepam Mono-Perchlorate
9.
Flurazepam Monohydrochloride
10.
Staurodorm
11.
Apo Flurazepam
12.
Dihydrochloride, Flurazepam
13.
Flurazepam Mono Perchlorate
14.
Hydrochloride, Flurazepam
15.
Mono-Perchlorate, Flurazepam
16.
Monohydrochloride, Flurazepam
External Link(s)
| MeSH | D005479 |
| PubChem Compound | 14434 |
| ChEBI | 5129 |
| CHEMBL | CHEMBL3989724 |
| KEGG | dr:D00695 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Somnolence | FAERS: 10 | US FAERS | |
| 2 | Suicide attempt | FAERS: 9 | US FAERS | |
| 3 | Overdose | FAERS: 6 | US FAERS | |
| 4 | Drug ineffective | FAERS: 5 | US FAERS | |
| 5 | Drug Dependence | FAERS: 4 | US FAERS | |
| 6 | Product quality issue | FAERS: 4 | US FAERS | |
| 7 | Wrong technique in product usage process | FAERS: 4 | US FAERS | |
| 8 | Completed Suicide | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Drug ineffective for unapproved indication | FAERS: 3 | US FAERS | |
| 10 | Incorrect dose administered | FAERS: 3 | US FAERS | |
| 11 | Drug toxicity | FAERS: 2 | US FAERS | |
| 12 | Nausea | FAERS: 2 | US FAERS | |
| 13 | Product availability issue | FAERS: 2 | US FAERS | |
| 14 | Sluggishness | FAERS: 2 | US FAERS | |
| 15 | Amnesia | FAERS: 1 | US FAERS | |
| 16 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 17 | Bradycardia | FAERS: 1 | US FAERS | |
| 18 | Dizziness | FAERS: 1 | US FAERS | |
| 19 | Drug abuse | FAERS: 1 | US FAERS | |
| 20 | Drug administration error | FAERS: 1 | US FAERS | |
| 21 | Drug screen positive | FAERS: 1 | US FAERS | |
| 22 | Dysarthria | FAERS: 1 | US FAERS | |
| 23 | Emotional disorder | FAERS: 1 | US FAERS | |
| 24 | Expired product administered | FAERS: 1 | US FAERS | |
| 25 | Fatigue | FAERS: 1 | US FAERS | |
| 26 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 27 | Headache | FAERS: 1 | US FAERS | |
| 28 | Hepatic congestion | FAERS: 1 | US FAERS | |
| 29 | Hyperacusis | FAERS: 1 | US FAERS | |
| 30 | Hypotension | FAERS: 1 | US FAERS | |
| 31 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 32 | Medication Error | FAERS: 1 | US FAERS | |
| 33 | No adverse event | FAERS: 1 | US FAERS | |
| 34 | Palpitations | FAERS: 1 | US FAERS | |
| 35 | Pulmonary congestion | FAERS: 1 | US FAERS | |
| 36 | Respiratory Depression | FAERS: 1 | US FAERS | |
| 37 | Sopor | FAERS: 1 | US FAERS | |
| 38 | Spontaneous penile erection | FAERS: 1 | US FAERS | |
| 39 | Tinnitus | FAERS: 1 | US FAERS | |
| 40 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 41 | Unevaluable event | FAERS: 1 | US FAERS | |
| 42 | Vomiting | FAERS: 1 | US FAERS | |
| 43 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 44 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Drug level increased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.